Date: 28 January 2026
Time: 10:00 – 15:00
Location: Oslo Science Park - Forskningsparken
In January, Immudex will be hosting a symposium in Oslo where scientists will give presentations about their research in the area of T cells and antigen specifity.
This event is free to attend but the number of places is limited so please register to secure your seat.
| 9:30 - 10:00 | Welcome coffee |
| 10:00 - 10:30 |
“Found by Tetramer, Judged by Phenotype: A CD8⁺ T Cell’s Hard Life.” Dr. Hassen Kared Researcher, Dept. of Immunology, University of Oslo |
| 10:30 - 11:00 |
“From Epitope to Therapy - Selecting the Right T cell for the Job” Dr. Thomas Holberg Blicher Principal Scientist, Immudex |
| 11:00 - 11:30 |
"Identifying rare antigen-specific B cells” Dr. Rasmus Iversen Researcher, Dept. of Immunology, Oslo University Hospital |
| 11:30 - 12:00 |
“Profiling gluten-specific CD4+ T cells using HLA-DQ: gluten tetramers in celiac disease” Dr. Louise Fremgaard Risnes Researcher, Dept. of Transplantation Medicine, Oslo University Hospital |
| 12:00 - 13:00 | Lunch & Get together |
| 13:00 - 13:30 |
“Measuring antigen-specific T-cell immunity in cancer patients treated with immunotherapy” Dr. Else Marit Inderberg Principal Investigator & Head of Immunomonitoring, Oslo University Hospital |
| 13:30 - 14:00 |
“Antigen design for cross-reactive influenza vaccine” Dr. Ranveig Braathen Senior Researcher & Group Leader, IMM, Dep. of Immunol, OUS, Rikshospitalet |
| 14:00 - 14:30 |
“Obesity and immune formation after vaccination" Dr. Gunnveig Grødeland Professor, Centre for Pandemics and One-Health Research & Dept. of Immunology, University of Oslo |
| 14:30 - 15:00 | Closing remarks & Networking |

Michela Venturi, PhD
Sales Development Manager



Thomas Holberg Blicher, PhD
Principal Scientist